Literature DB >> 2550437

Tumor necrosis factor acts synergistically with autocrine interferon-beta and increases interferon-beta mRNA levels in human fibroblasts.

L F Reis1, T Ho Lee, J Vilcek.   

Abstract

Medium of untreated human FS-4 foreskin fibroblasts contained a factor which, upon the addition of exogenous tumor necrosis factor (TNF), inhibited encephalomyocarditis virus replication when neither medium alone nor TNF alone were effective. This antiviral activity was abolished by a monoclonal antibody to human interferon (IFN)-beta, suggesting that the active component in the medium from untreated FS-4 cells was IFN-beta, present at subeffective concentrations. In addition, we show that untreated FS-4 cells contain IFN-beta mRNA, demonstrable by the highly sensitive polymerase chain reaction after reverse transcription. Treatment of FS-4 cells with TNF produced an approximately 16-fold increase in the steady-state level of IFN-beta mRNA. Our results support the conclusion that autocrine IFN-beta is secreted by untreated normal fibroblasts and that TNF can enhance the production of autocrine IFN-beta by increasing the level of IFN-beta mRNA. Our study also demonstrates that subeffective concentrations of autocrine IFN-beta, which escape detection in conventional assays, are sufficient to produce a strong synergistic action with TNF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550437

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway.

Authors:  I P Cerávolo; A C Chaves; C A Bonjardim; D Sibley; A J Romanha; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathways.

Authors:  Kongthawat Chairatvit; Ariyaphong Wongnoppavich; Sirinthip Choonate
Journal:  Mol Cell Biochem       Date:  2012-06-23       Impact factor: 3.396

3.  From IFN to TNF: a journey into realms of lore.

Authors:  Jan Vilcek
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

4.  Induction of c-Ha-ras gene expression by double-stranded RNA and interferon requirement.

Authors:  A Maran; I D Goldberg; B M Steinberg
Journal:  Mol Cell Biol       Date:  1990-08       Impact factor: 4.272

5.  Highly sensitive detection of gene expression of an intronless gene: amplification of mRNA, but not genomic DNA by nucleic acid sequence based amplification (NASBA).

Authors:  A Heim; I M Grumbach; S Zeuke; B Top
Journal:  Nucleic Acids Res       Date:  1998-05-01       Impact factor: 16.971

6.  Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence.

Authors:  Y H Zhang; J X Lin; J Vilcek
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

7.  Arenavirus nucleoproteins prevent activation of nuclear factor kappa B.

Authors:  W W Shanaka I Rodrigo; Emilio Ortiz-Riaño; Christelle Pythoud; Stefan Kunz; Juan C de la Torre; Luis Martínez-Sobrido
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

8.  Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

Authors:  T Fujita; L F Reis; N Watanabe; Y Kimura; T Taniguchi; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Induced expression of the endogenous beta interferon gene in adenovirus type 5-transformed rat fibroblasts.

Authors:  U Nielsch; R Pine; S G Zimmer; L E Babiss
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

Review 10.  Type I IFN and TNFα cross-regulation in immune-mediated inflammatory disease: basic concepts and clinical relevance.

Authors:  Tineke Cantaert; Dominique Baeten; Paul P Tak; Lisa G M van Baarsen
Journal:  Arthritis Res Ther       Date:  2010-10-28       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.